Current
2.0×
5-Year Average
1.7×
All-Time High
2.2×
All-Time Low
1.0×
P/S Ratio daily chart for Quest Diagnostics (DGX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Quest Diagnostics (DGX) from 2001 to 2025
| 2025 | $19.26B | $11.04B | 1.7× | +0.0× | |
| 2024 | $16.75B | $9.87B | 1.7× | +0.0× | |
| 2023 | $15.44B | $9.25B | 1.7× | -0.1× | |
| 2022 | $17.68B | $9.88B | 1.8× | -0.2× | |
| 2021 | $21.11B | $10.79B | 2.0× | +0.3× | |
| 2020 | $16.09B | $9.44B | 1.7× | -0.1× | |
| 2019 | $14.31B | $7.73B | 1.9× | +0.3× | |
| 2018 | $11.32B | $7.53B | 1.5× | -0.2× | |
| 2017 | $13.39B | $7.71B | 1.7× | +0.0× | |
| 2016 | $12.68B | $7.51B | 1.7× | +0.3× | |
| 2015 | $10.17B | $7.49B | 1.4× | +0.0× | |
| 2014 | $9.72B | $7.43B | 1.3× | +0.2× | |
| 2013 | $7.82B | $7.15B | 1.1× | -0.1× | |
| 2012 | $9.25B | $7.47B | 1.2× | +0.0× | |
| 2011 | $9.19B | $7.51B | 1.2× | +0.0× | |
| 2010 | $8.72B | $7.37B | 1.2× | -0.3× | |
| 2009 | $10.88B | $7.46B | 1.5× | +0.1× | |
| 2008 | $9.83B | $7.25B | 1.4× | -0.2× | |
| 2007 | $10.24B | $6.70B | 1.5× | -0.1× | |
| 2006 | $10.25B | $6.27B | 1.6× | -0.2× | |
| 2005 | $10.21B | $5.50B | 1.9× | -0.0× | |
| 2004 | $9.57B | $5.13B | 1.9× | +0.3× | |
| 2003 | $7.54B | $4.74B | 1.6× | +0.2× | |
| 2002 | $5.52B | $4.11B | 1.3× | -0.5× | |
| 2001 | $6.83B | $3.63B | 1.9× | — |
- 20251.7×
- 20241.7×
- 20231.7×
- 20221.8×
- 20212.0×
- 20201.7×
- 20191.9×
- 20181.5×
- 20171.7×
- 20161.7×
- 20151.4×
- 20141.3×
- 20131.1×
- 20121.2×
- 20111.2×
- 20101.2×
- 20091.5×
- 20081.4×
- 20071.5×
- 20061.6×
- 20051.9×
- 20041.9×
- 20031.6×
- 20021.3×
- 20011.9×
About P/S Ratio at Quest Diagnostics (DGX)
Quest Diagnostics (DGX) P/S ratio is 2.0× as of June 5, 2026. The 5-year average is 1.7×. The sector median currently stands at 3.5×. The current ratio is at the 94th percentile of its own 10-year history.
Quest Diagnostics (DGX) historical P/S ratio has ranged from a low of 1.0× (2011) to a high of 2.2× (2026) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Quest Diagnostics P/S Ratio by Year
Quest Diagnostics P/S Ratio 2025: 1.7×
Quest Diagnostics (DGX) P/S ratio in 2025 was 1.7×, expanded from 1.7× the prior year.
Quest Diagnostics P/S Ratio 2024: 1.7×
Quest Diagnostics (DGX) P/S ratio in 2024 was 1.7×, expanded from 1.7× the prior year.
Quest Diagnostics P/S Ratio 2023: 1.7×
Quest Diagnostics (DGX) P/S ratio in 2023 was 1.7×, contracted from 1.8× the prior year.
Quest Diagnostics P/S Ratio 2022: 1.8×
Quest Diagnostics (DGX) P/S ratio in 2022 was 1.8×, contracted from 2.0× the prior year.
Quest Diagnostics P/S Ratio 2021: 2.0×
Quest Diagnostics (DGX) P/S ratio in 2021 was 2.0×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Quest Diagnostics (DGX), ranked by P/S ratio.
| 2.5× | |
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.5×
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric